HRT Financial’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,039
| Closed | -$290K | – | 2498 |
|
|
2025
Q1 | $290K | Buy |
+51,039
| New | +$290K | ﹤0.01% | 1587 |
|
|
2024
Q3 | – | Sell |
-119,487
| Closed | -$1.6M | – | 2391 |
|
|
2024
Q2 | $1.6M | Buy |
119,487
+72,292
| +153% | +$966K | 0.01% | 771 |
|
|
2024
Q1 | $2.19M | Buy |
47,195
+39,477
| +511% | +$1.83M | 0.01% | 513 |
|
|
2023
Q4 | $521K | Sell |
7,718
-36,432
| -83% | -$2.46M | ﹤0.01% | 1231 |
|
|
2023
Q3 | $3.2M | Buy |
+44,150
| New | +$3.2M | 0.03% | 403 |
|
|
2023
Q2 | – | Sell |
-9,164
| Closed | -$487K | – | 2422 |
|
|
2023
Q1 | $487K | Buy |
+9,164
| New | +$487K | 0.01% | 1313 |
|
|
2022
Q4 | – | Sell |
-11,368
| Closed | -$1.42M | – | 2403 |
|
|
2022
Q3 | $1.42M | Buy |
+11,368
| New | +$1.42M | 0.02% | 708 |
|
|
2022
Q2 | – | Sell |
-190,064
| Closed | -$30.6M | – | 2963 |
|
|
2022
Q1 | $30.6M | Buy |
+190,064
| New | +$30.6M | 0.22% | 52 |
|
|
2021
Q4 | – | Sell |
-5,831
| Closed | -$2.7M | – | 3046 |
|
|
2021
Q3 | $2.7M | Buy |
+5,831
| New | +$2.7M | 0.02% | 506 |
|